首页> 美国卫生研究院文献>The Journal of Physiology >β‐Adrenergic modulation of skeletal muscle contraction: key role of excitation–contraction coupling
【2h】

β‐Adrenergic modulation of skeletal muscle contraction: key role of excitation–contraction coupling

机译:骨骼肌收缩的β-肾上腺素能调节:兴奋与收缩耦合的关键作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Our aim is to describe the acute effects of catecholamines/β‐adrenergic agonists on contraction of non‐fatigued skeletal muscle in animals and humans, and explain the mechanisms involved. Adrenaline/β‐agonists (0.1–30 μm) generally augment peak force across animal species (positive inotropic effect) and abbreviate relaxation of slow‐twitch muscles (positive lusitropic effect). A peak force reduction also occurs in slow‐twitch muscles in some conditions. β2‐Adrenoceptor stimulation activates distinct cyclic AMP‐dependent protein kinases to phosphorylate multiple target proteins. β‐Agonists modulate sarcolemmal processes (increased resting membrane potential and action potential amplitude) via enhanced Na+–K+ pump and Na+–K+–2Cl cotransporter function, but this does not increase force. Myofibrillar Ca2+ sensitivity and maximum Ca2+‐activated force are unchanged. All force potentiation involves amplified myoplasmic Ca2+ transients consequent to increased Ca2+ release from sarcoplasmic reticulum (SR). This unequivocally requires phosphorylation of SR Ca2+ release channels/ryanodine receptors (RyR1) which sensitize the Ca2+‐induced Ca2+ release mechanism. Enhanced trans‐sarcolemmal Ca2+ influx through phosphorylated voltage‐activated Ca2+ channels contributes to force potentiation in diaphragm and amphibian muscle, but not mammalian limb muscle. Phosphorylation of phospholamban increases SR Ca2+ pump activity in slow‐twitch fibres but does not augment force; this process accelerates relaxation and may depress force. Greater Ca2+ loading of SR may assist force potentiation in fast‐twitch muscle. Some human studies show no significant force potentiation which appears to be related to the β‐agonist concentration used. Indeed high‐dose β‐agonists (∼0.1 μm) enhance SR Ca2+‐release rates, maximum voluntary contraction strength and peak Wingate power in trained humans. The combined findings can explain how adrenaline/β‐agonists influence muscle performance during exercise/stress in humans.
机译:我们的目的是描述儿茶酚胺/β-肾上腺素能激动剂对动物和人的无疲劳骨骼肌收缩的急性作用,并解释其中的机制。肾上腺素/β激动剂(0.1–30μm)通常会增加整个动物的峰值力(正性肌力作用)并减慢慢肌的松弛(正性肌力作用)。在某些情况下,缓慢抽搐的肌肉也会出现峰值力量降低。 β2-肾上腺素受体刺激可激活独特的依赖于AMP的环状蛋白激酶,以磷酸化多种靶蛋白。 β‐激动剂通过增强Na + –K + 泵和Na + –K调节肌膜过程(静息膜电位和动作电位振幅增加) + –2Cl -共转运蛋白功能,但这不会增加作用力。肌原纤维Ca 2 + 的敏感性和最大Ca 2 + 激活的力不变。所有的力增强作用都涉及增加的肌质Ca 2 + 瞬变,这是由于肌浆网(SR)释放的Ca 2 + 增加。这明确要求SR Ca 2 + 释放通道/ ryanodine受体(RyR1)磷酸化,从而使Ca 2 + 诱导的Ca 2 + 释放敏感机制。通过磷酸化的电压激活的Ca 2 + 通道增强的跨肌膜Ca 2 + 内流有助于在diaphragm肌和两栖肌肉中增强作用,而在哺乳动物肢体肌肉中则没有作用。磷酸lamban的磷酸化增加了慢扭纤维中SR Ca 2 + 的泵浦活性,但没有增加力。这个过程会加速放松并可能降低力量。 SR较高的Ca 2 + 负荷可能有助于快速抽搐肌肉的力量增强。一些人体研究表明,没有显着的力增强作用,这似乎与所用的β激动剂浓度有关。实际上,大剂量的β受体激动剂(〜0.1μm)可以提高受过训练的人类的SR Ca 2 + -释放速率,最大的自愿收缩强度和Wingate峰值功率。合并的发现可以解释肾上腺素/β激动剂如何影响人类运动/应激时的肌肉表现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号